# Effect of different material protocols on the control of dentin hypersensitivity: a split-mouth randomized controlled clinical trial

**Authors:** Júlia Marques Martins, Maria Fernanda Ferreira Nogueira, Guilherme José Pimentel Lopes de Oliveira, Alexandre Coelho Machado, Paulo César de Freitas Santos Filho, Hugo Lemes Carlo, Carlos José Soares, Gisele Rodrigues da Silva

PMC · DOI: 10.1007/s00784-026-06776-0 · Clinical Oral Investigations · 2026-02-28

## TL;DR

This study compared three dental treatments for sensitivity and found they all worked equally well for up to 180 days.

## Contribution

The study shows that adding adhesive and resin steps does not improve outcomes for dentin hypersensitivity treatment.

## Key findings

- All three protocols reduced pain intensity over time with no significant differences between them.
- Oral health-related quality of life improved significantly at 90 and 180 days for all protocols.
- More complex treatment steps did not lead to better patient outcomes.

## Abstract

To compare the efficacy of three desensitizing protocols for dentin hypersensitivity (DH) pain control and their impact on oral health–related quality of life (OHRQoL) up to 180 days.

In this randomized controlled split-mouth clinical trial, 33 participants (99 teeth) were randomized and treated; 31 participants (93 teeth) were analyzed (mITT). Participants received three protocols: GLU: 3% potassium nitrate + glutaraldehyde/HEMA desensitizer (control); GAS: 3% potassium nitrate + glutaraldehyde/HEMA desensitizer + universal adhesive; and GAR: 3% potassium nitrate + glutaraldehyde/HEMA desensitizer + universal adhesive + bulk-fill flowable resin. Pain intensity was recorded using the Numeric Rating Scale (NRS; 0–10) after standardized air-blast and tactile stimuli at baseline, immediately after intervention, and at 7, 30, 90, and 180 days. OHRQoL was assessed using OHIP-14 at baseline, 90, and 180 days.

NRS scores decreased over time for both stimuli (air-blast: p < 0.001; tactile: p < 0.001). No differences were observed among protocols (air-blast: p = 0.910; tactile: p = 0.681) and no time × protocol interaction was detected (air-blast: p = 0.341; tactile: p = 0.738). OHIP-14 scores improved at 90 and 180 days versus baseline (p < 0.001).

The three protocols produced comparable patient-centered outcomes, indicating that adding adhesive and resin steps to potassium nitrate + glutaraldehyde/HEMA does not enhance DH pain control or OHRQoL up to 180 days.

Increasing complexity with adhesive and resin steps was not associated with superior patient-centered outcomes within 180 days.

RBR-109h3wcv.

## Linked entities

- **Chemicals:** potassium nitrate (PubChem CID 24434), glutaraldehyde (PubChem CID 3485), HEMA (PubChem CID 13360)

## Full-text entities

- **Diseases:** gastroesophageal disorder (MESH:D005764), trauma (MESH:D014947), loss (MESH:D016388), Pain (MESH:D010146), enamel loss (MESH:D003744), gingival recession (MESH:D005889), tooth malposition (MESH:D017760), tooth structure (MESH:D020914), dental defect (MESH:D009057), Mucosa (MESH:D018442), gingivitis (MESH:D005891), cytotoxicity (MESH:D064420), caries (MESH:D003731), DH (MESH:D003807), occlusal disharmony (MESH:D001157), inflammatory periodontal diseases (MESH:D010510), gingival bleeding (MESH:D005884), inflammatory drugs (MESH:D000081015), pulpitis (MESH:D011671), hypersensitive (MESH:D004342)
- **Chemicals:** GLU (MESH:D018698), ethanol (MESH:D000431), SP (MESH:C000604007), Gluma (MESH:C044372), water (MESH:D014867), fluoride (MESH:D005459), HEMA (MESH:C005044), propolis (MESH:D011429), Potassium nitrate (MESH:C023844), Opus Bulk Fill (-), silica (MESH:D012822), glutaraldehyde (MESH:D005976), GAS (MESH:D005708), Gluma Desensitizer (MESH:C111486)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12948845/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12948845/full.md

---
Source: https://tomesphere.com/paper/PMC12948845